Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Head and Neck Cancer

Free Subscription 27.06.2022 1 Am J Ophthalmol 1 Am J Pathol 3 Ann Otol Rhinol Laryngol 4 BMC Cancer 1 BMC Surg 1 Cancer 1 Dis Esophagus 6 Head Neck 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 6 J Clin Endocrinol Metab 2 J Clin Oncol 1 J Nucl Med 6 Laryngoscope 1 Minerva Surg 4 Oral Oncol 3 PLoS One 1 Radiology 8 Radiother Oncol 3 Surgery 6 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Ophthalmol

1. SUN H, Cai R, Zhai C, Song W, et al
   Primary Mucoepidermoid Carcinoma of the Lacrimal Apparatus.
   Am J Ophthalmol. 2022;239:170-179.
   PubMed         Abstract available
   
   

   
   Am J Pathol

2. BLOCKER SJ, Cook J, Everitt JI, Austin WM, et al
   Automated nuclear segmentation in head and neck squamous cell carcinoma (HNSCC) pathology reveals relationships between cytometric features and ESTIMATE stromal and immune scores.
   Am J Pathol. 2022 Jun 16. pii: S0002-9440(22)00173.
   PubMed         Abstract available
   
   

   
   Ann Otol Rhinol Laryngol

3. ROCH M, Mauvais O, Vergez S, Brenet E, et al
   Is Revision Surgery Necessary for Patients With High Risk of Recurrence After Parotidectomy? A Multicenter Retrospective Study.
   Ann Otol Rhinol Laryngol. 2022;131:782-790.
   PubMed         Abstract available
   
   
4. MASCARELLA MA, Muthukrishnan N, Maleki F, Kergoat MJ, et al
   Above and Beyond Age: Prediction of Major Postoperative Adverse Events in Head and Neck Surgery.
   Ann Otol Rhinol Laryngol. 2022;131:697-703.
   PubMed         Abstract available
   
   
5. SALLEY JR, Day AT, Balachandra S, Mehr J, et al
   Adherence to the American Cancer Society Head and Neck Cancer Survivorship Care Guideline According to Chart Review: A Nested Retrospective Cohort Pilot Study.
   Ann Otol Rhinol Laryngol. 2022 Jun 20:34894221098471.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. SHI J, Wang L, Yao N, Sun L, et al
   The effect of HPV DNA and p16 status on the prognosis of patients with hypopharyngeal carcinoma: a meta-analysis.
   BMC Cancer. 2022;22:658.
   PubMed         Abstract available
   
   
7. LIN Z, Rao W, Xiang Z, Zeng Q, et al
   Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma.
   BMC Cancer. 2022;22:696.
   PubMed         Abstract available
   
   
8. ZHOU G, Zhang S, Jin M, Hu S, et al
   Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
   BMC Cancer. 2022;22:667.
   PubMed         Abstract available
   
   
9. SHAVER AL, Platek ME, Singh AK, Ma SJ, et al
   Effect of musculature on mortality, a retrospective cohort study.
   BMC Cancer. 2022;22:688.
   PubMed         Abstract available
   
   

   
   BMC Surg

10. ZHAN L, Feng HF, Yu XZ, Li LR, et al
    Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma.
    BMC Surg. 2022;22:235.
    PubMed         Abstract available
    
    

    
    Cancer

11. 
    Erratum to "Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study".
    Cancer. 2022 Jun 24. doi: 10.1002/cncr.34358.
    PubMed        
    
    

    
    Dis Esophagus

12. LEE AHH, Oo J, Cabalag CS, Link E, et al
    Increased risk of diaphragmatic herniation following esophagectomy with a minimally invasive abdominal approach.
    Dis Esophagus. 2022;35.
    PubMed         Abstract available
    
    

    
    Head Neck

13. AL-QURAYSHI Z, Sullivan CB, Allison DB, Buchakjian MR, et al
    Presentation and outcomes of patients with clinically T1-2, N0 parotid mucoepidermoid carcinoma: The roles of elective neck dissection and adjuvant radiotherapy.
    Head Neck. 2022 Jun 22. doi: 10.1002/hed.27128.
    PubMed         Abstract available
    
    
14. DAI Y, Wang Z, Yan E, Li J, et al
    Development of a novel signature derived from single cell RNA-sequencing for preoperative prediction of lymph node metastasis in head and neck squamous cell carcinoma.
    Head Neck. 2022 Jun 21. doi: 10.1002/hed.27126.
    PubMed         Abstract available
    
    
15. SHAO YF, Kim S, Cramer JD, Farhat D, et al
    African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27107.
    PubMed         Abstract available
    
    
16. COSTANTINO A, Canali L, Festa BM, Spriano G, et al
    Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27121.
    PubMed         Abstract available
    
    
17. DENISSOFF A, Huusko T, Ventela S, Niemela S, et al
    Exposure to alcohol and overall survival in head and neck cancer: A regional cohort study.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27125.
    PubMed         Abstract available
    
    
18. YANG A, Tanamal P, Tibbetts K, Sumer B, et al
    Characteristics and outcomes of young patients with laryngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2022 Jun 16. doi: 10.1002/hed.27120.
    PubMed         Abstract available
    
    

    
    Int J Cancer

19. LIU Y, Zheng Z, Li M, Zhang Y, et al
    Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
    Int J Cancer. 2022;151:607-615.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

20. ANDERSON CM, Lee CM, Saunders D, Curtis AE, et al
    Two-Year Tumor Outcomes of Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiation Therapy and Ciplatin for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 17. pii: S0360-3016(22)00608.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

21. PAPPA T, Ahmadi S, Bikas A, Hwang S, et al
    Thyroid nodule shape independently predicts risk of malignancy.
    J Clin Endocrinol Metab. 2022 Apr 19. pii: 6570820. doi: 10.1210.
    PubMed         Abstract available
    
    
22. HUANG L, Feng X, Yang W, Li X, et al
    Appraising the effect of potential risk factors on thyroid cancer: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Apr 2. pii: 6562772. doi: 10.1210.
    PubMed         Abstract available
    
    
23. ZHAO ZL, Wei Y, Peng LL, Li Y, et al
    Recurrent Laryngeal Nerve Injury in Thermal Ablation of Thyroid Nodules - Risk Factors and Cause Analysis.
    J Clin Endocrinol Metab. 2022 Mar 21. pii: 6551221. doi: 10.1210.
    PubMed         Abstract available
    
    
24. XING M
    Response to Letter to the Editor from Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545262. doi: 10.1210.
    PubMed        
    
    
25. ROTONDI M, Chiovato L
    Pre-existing or concomitant thyroiditis in papillary thyroid cancer: Something more than a mere issue of timing?
    J Clin Endocrinol Metab. 2021 Dec 20. pii: 6470727. doi: 10.1210.
    PubMed        
    
    
26. SAVVATEEVA M, Kudryavtseva A, Lukyanova E, Kobelyatskaya A, et al
    Somatic Mutation Profiling in Head and Neck Paragangliomas.
    J Clin Endocrinol Metab. 2022;107:1833-1842.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

27. ZHANG Y, Chen L, Hu GQ, Zhang N, et al
    Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.
    J Clin Oncol. 2022 Jun 16:JCO2200327. doi: 10.1200/JCO.22.00327.
    PubMed         Abstract available
    
    
28. NORONHA V, Patil VM, Menon N, Prabhash K, et al
    Change in Pattern of Failure in Head and Neck Cancer.
    J Clin Oncol. 2022 Jun 16:JCO2200598. doi: 10.1200/JCO.22.00598.
    PubMed        
    
    

    
    J Nucl Med

29. ZHENG KH, Kroon J, Schoormans J, Gurney-Champion O, et al
    (89)Zr-labeled High-Density Lipoprotein Nanoparticle PET imaging reveals tumor uptake in patients with esophageal cancer.
    J Nucl Med. 2022 Jun 23. pii: jnumed.121.263330. doi: 10.2967/jnumed.121.263330.
    PubMed         Abstract available
    
    

    
    Laryngoscope

30. PANWAR A, McGill T, Lydiatt D, Militsakh O, et al
    De-Novo Depression, Prophylactic Antidepressant, and Survival in Patients With Head and Neck Cancer.
    Laryngoscope. 2022 Jun 22. doi: 10.1002/lary.30249.
    PubMed         Abstract available
    
    
31. LEDDEROSE S, Ledderose C, Penkava J, Ledderose GJ, et al
    Prognostic Value of Tumor-Infiltrating Lymphocytes in Sinonasal Mucosal Melanoma.
    Laryngoscope. 2022;132:1334-1339.
    PubMed         Abstract available
    
    
32. LECHIEN JR, Crevier-Buchman L, Circiu MP, Lisan Q, et al
    Evolution of Voice Quality in Type 1-2 Transoral CO2 Laser Cordectomy: A Prospective Comparative Study.
    Laryngoscope. 2022;132:1421-1426.
    PubMed         Abstract available
    
    
33. MANI S, Anbarasan S, Panda S, Kumar R, et al
    In Reference to Radiological Findings in Laryngeal Anterior Commissure Invasion: CT Scan Highlights.
    Laryngoscope. 2022;132:E27.
    PubMed        
    
    
34. BOSCOLO NATA F, Cristalli G
    In Response to Radiological Findings in Laryngeal Anterior Commissure Invasion: Computed Tomography Scan Highlights.
    Laryngoscope. 2022;132:E26.
    PubMed        
    
    
35. MEGWALU UC, Osazuwa-Peters N, Moon P, Palaniappan LP, et al
    Thyroid Cancer Incidence Trends Among Filipinos in the United States.
    Laryngoscope. 2022;132:1495-1502.
    PubMed         Abstract available
    
    

    
    Minerva Surg

36. RIZZUTO A, Amaddeo A, Bozzarello C, Curro G, et al
    Strategies to decrease morbidity in surgical management of esophageal cancer: a single center experience.
    Minerva Surg. 2022 Jun 16. pii: S2724-5691.22.09627.
    PubMed         Abstract available
    
    

    
    Oral Oncol

37. SEKARAN S, Pitchaiah S, Ganapathy D
    Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer?
    Oral Oncol. 2022;131:105973.
    PubMed        
    
    
38. ZONG J, Ji P, Lin C, Zhang R, et al
    Plasma Epstein-Barr viral DNA load after completion of two cycles of induction chemotherapy predicts outcomes for patients with advanced-stage nasopharyngeal carcinoma.
    Oral Oncol. 2022;131:105972.
    PubMed         Abstract available
    
    
39. GANAPATHY D, Sekaran S, Pitchaiah S
    Is prognostic monitoring of high-risk populations at risk for oral cancer necessary after infection with COVID-19?
    Oral Oncol. 2022;131:105968.
    PubMed        
    
    
40. BALACHANDER K, Paramasivam A
    Ferroptosis: An emerging therapeutic target for oral cancer.
    Oral Oncol. 2022;131:105970.
    PubMed        
    
    

    
    PLoS One

41. DU Q, Xiao RD, Luo RG, Xie JB, et al
    Construction of long non-coding RNA- and microRNA-mediated competing endogenous RNA networks in alcohol-related esophageal cancer.
    PLoS One. 2022;17:e0269742.
    PubMed         Abstract available
    
    
42. LIANG Y, Huang X, Song Z, Yang Y, et al
    Clinical study of ultrasonic evaluation of T/N staging of differentiated thyroid carcinoma using AJCC 8th staging criteria.
    PLoS One. 2022;17:e0269994.
    PubMed         Abstract available
    
    
43. TANG Q, Pan W, Peng L
    Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis.
    PLoS One. 2022;17:e0269995.
    PubMed         Abstract available
    
    

    
    Radiology

44. LEVINE D
    O-RADS US: A Retrospective Assessment of Prediction of Malignancy in a High-Risk Setting.
    Radiology. 2022;304:121-122.
    PubMed        
    
    

    
    Radiother Oncol

45. PRICE JM, West CM, Dixon LM, Iyizoba-Ebozue Z, et al
    Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study.
    Radiother Oncol. 2022;172:111-117.
    PubMed         Abstract available
    
    
46. WANG J, Liu Y, Shayan G, Ma Y, et al
    Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
    Radiother Oncol. 2022;172:83-90.
    PubMed         Abstract available
    
    
47. NIU X, Liu P, Zhou X, Wang X, et al
    Is postoperative radiotherapy an essential treatment for nonmetastatic lymphoepithelial carcinoma of the salivary gland?
    Radiother Oncol. 2022;172:76-82.
    PubMed         Abstract available
    
    
48. FRIED DV, Zhu T, Das SK, Shen C, et al
    Prospective assessment of sparing the parotid ducts via MRI sialography for reducing patient reported xerostomia.
    Radiother Oncol. 2022;172:42-49.
    PubMed         Abstract available
    
    
49. HOFFMANN L, Mortensen H, Shamshad M, Berbee M, et al
    Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres.
    Radiother Oncol. 2022;172:32-41.
    PubMed         Abstract available
    
    
50. GONG J, Zhang W, Huang W, Liao Y, et al
    CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: a multicenter study.
    Radiother Oncol. 2022 Jun 21. pii: S0167-8140(22)04171.
    PubMed         Abstract available
    
    
51. FU G, Xie Y, Pan J, Qiu Y, et al
    Longitudinal study of irradiation-induced brain functional network alterations in patients with nasopharyngeal carcinoma.
    Radiother Oncol. 2022 Jun 16. pii: S0167-8140(22)04164.
    PubMed         Abstract available
    
    
52. HANSEN CR, Price G, Field M, Sarup N, et al
    Open-source distributed learning validation for a larynx cancer survival model following radiotherapy.
    Radiother Oncol. 2022 Jun 20. pii: S0167-8140(22)04170.
    PubMed         Abstract available
    
    

    
    Surgery

53. GOOSZEN JAH, Eshuis WJ, Blom RLGM, van Dieren S, et al
    The effect of preoperative body mass index on short-term outcome after esophagectomy for cancer: A nationwide propensity score-matched analysis.
    Surgery. 2022;172:137-144.
    PubMed         Abstract available
    
    
54. DING AS, Xie DX, Zhang L, Creighton FX, et al
    Public perceptions of radiofrequency ablation versus standard surgery for benign thyroid nodules.
    Surgery. 2022 Mar 2. pii: S0039-6060(22)00062-9. doi: 10.1016/j.surg.2022.
    PubMed         Abstract available
    
    
55. ABE T, Oshikiri T, Goto H, Kato T, et al
    Thoracic cavity-to-cage ratio is a predictor of technical difficulties in minimally invasive esophagectomy.
    Surgery. 2022;172:145-149.
    PubMed         Abstract available
    
    

    
    Thyroid

56. CHOU R, Dana T, Brent GA, Goldner W, et al
    Serum Thyroglobulin Measurement Following Surgery without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review.
    Thyroid. 2022 Apr 12. doi: 10.1089/thy.2021.0666.
    PubMed         Abstract available
    
    
57. MA LX, Espin-Garcia O, Bedard PL, Stockley TL, et al
    Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.
    Thyroid. 2022 Mar 9. doi: 10.1089/thy.2021.0542.
    PubMed         Abstract available
    
    
58. MURI R, Trippel M, Borner U, Weidner SE, et al
    The impact of rapid on-site evaluation (ROSE) on the quality and diagnostic value of thyroid nodule fine-needle aspirations.
    Thyroid. 2022 Mar 2. doi: 10.1089/thy.2021.0551.
    PubMed         Abstract available
    
    
59. HOANG JK, Asadollahi S, Durante C, Hegedus L, et al
    An International Survey on Utilization of Five Thyroid Nodule Risk Stratification Systems: A Needs Assessment with Future Implications.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0558.
    PubMed         Abstract available
    
    
60. TOFT DJ, Schneider AB
    PROTECTING THE THYROID IN TIMES OF CONFLICT (UKRAINE 2022).
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2022.0135.
    PubMed         Abstract available
    
    
61. KIM K, Choi JY, Kim SJ, Lee EK, et al
    Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study.
    Thyroid. 2022 May 16. doi: 10.1089/thy.2021.0679.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: